Abstract
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration
Author(s): Trissel Lawrence A, Xu Quanyun A
Issue: May/Jun 2005 - Veterinary Compounding
Page(s): 238-241
Abstract
The objective of this study was to evaluate the physical and chemical stability of undiluted palonosetron hydrochloride 50 µg/mL in combination with topotecan hydrochloride 0.1 mg/mL or irinotecan hydrochloride 1 mg/mL in 5% dextrose injection during simulated Y-site administration. Triplicate test samples were prepared by admixing 5 mL of palonosetron hydrochloride with 5 mL of the topotecan hydrochloride or irinotecan hydrochloride admixture. Physical stability was assessed by using a multistep evaluation procedure that included both turbidimetric and particulate measurement as well as visual inspection. Chemical stability was assessed by using stability-indicating high-performance liquid chromatographic analytical techniques to determine drug concentrations. Evaluations were performed initially upon mixing and again 1 and 4 hours after mixing. The palonosetron hydrochloride-topotecan hydrochloride samples were clear and pale yellow when viewed in normal fluorescent room light. When viewed with a Tyndall beam, the samples had a slight haziness. The palonosetron hydrochloride-irinotecan hydrochloride samples were clear and colorless when viewed in normal fluorescent room light and with a Tyndall beam. Measured turbidities remained unchanged; particulate contents were low and changed little. High-performance liquid chromatographic analysis found that palonosetron hydrochloride, topotecan hydrochloride, and irinotecan hydrochloride remained stable throughout the 4- hour test. Little drug loss was observed. Palonosetron hydrochloride is physically compatible and chemically stable with topotecan hydrochloride and with irinotecan hydrochloride during Y-site administration.
Related Keywords
- palonosetron hydrochloride
- 5-HT3 receptor antagonist
- topotecan hydrochloride
- irinotecan hydrochloride
- cancer chemotherapy
- antiemetic
- emesis
- nausea
- vomiting
- stability
Related Categories
- CANCER AND AIDS
- GASTROENTEROLOGY
- PEER-REVIEWED
- STABILITIES, COMPATIBILITIES
Related Articles from IJPC
Issue/Page View/Buy |
Title/Author (Click for Abstract / Details / Purchase) |
---|---|
May/Jun 2005
Pg. 238-241
|
Author(s):
Trissel Lawrence A, Xu Quanyun A
|
Mar/Apr 2008
Pg. 170-173
|
|
Mar/Apr 2008
Pg. 156-160
|
|
Jul/Aug 2008
Pg. 368-371
|
|
Nov/Dec 2007
Pg. 520-524
|
|
Jan/Feb 2009
Pg. 78-80
|
|
Jul/Aug 2005
Pg. 320-322
|
Author(s):
Trissel Lawrence A, Zhang Yanping
|
May/Jun 2005
Pg. 235-237
|
Author(s):
Trissel Lawrence A, Xu Quanyun A
|
Sep/Oct 2008
Pg. 460-462
|
|
Jan/Feb 2002
Pg. 66-69
|
|
Jan/Feb 2002
Pg. 70-73
|
|
Nov/Dec 2018
Pg. 516-526
|
|
Jan/Feb 2017
Pg. 76-82
|
|
Jan/Feb 2007
Pg. 82-85
|
|
May/Jun 2006
Pg. 234-236
|
|
Sep/Oct 2013
Pg. 436-438
|
|
Jan/Feb 2002
Pg. 74-76
|
|
Jul/Aug 1998
Pg. 318-321
|
|
May/Jun 2020
Pg. 252-262
|
|
Jan/Feb 2018
Pg. 76-85
|